510(k) Report

510(k) · Cleared

Cleared

Renovis Cemented Hip System

K141370510(k) TraditionalCleared Sep 2, 201498-day reviewClass II21 CFR 888.3350

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Renovis Surgical Technologies, Inc. · JDI Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Cemented

Cleared on Sep 2, 2014 as substantially equivalent to K970351 (Smith & Nephew, Inc., Orthopaedic Div., 1997) and 1 other predicate after a 98-day review. Its family tree reaches back 1 generation to 1997.

Decided
Sep 2, 2014
Review
98 days
Class
Class II
Product code
JDI
Recalls
None
Predicates
2

Its longest line of descent runs back 1 generation to K963509 (1997). 2 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by generation 1 generation back: 1 other ancestor K963509 · Global Taper Tapered Hip System, GT Spectron · Smith & Nephew Richards, Inc. · 19970
  1. Root · 1 generation backK963509 Global Taper Tapered Hip System, GT SpectronSmith & Nephew Richards, Inc. · 1997
  2. This deviceK141370 Renovis Cemented Hip SystemRenovis Surgical Technologies, Inc. · 2014
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K963509Global Taper Tapered Hip System, GT SpectronSmith & Nephew Richards, Inc.1997—
0 (this device)K141370Renovis Cemented Hip SystemRenovis Surgical Technologies, Inc.2014—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710
FIG. 1 — Lineage of K141370, 1997–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JDI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JDI device

  1. #1 K253515 Zimmer Biomet OSS™ Orthopedic Salvage System…score 15.2 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K970351Global Taper Spectron Hip Stems
Summary page 4
…Device Class: Class II Regulation 21 CFR 888.3350 and Product Code: JDI Classification panel: Orthopedic C) Predicate: K970351, K963509 Smith & Nephew Global Taper Spectron Hip Stems (for cemented hip stems) D) Device Description…
Smith & Nephew, Inc., Orthopaedic Div.1997—
*K963509Global Taper Tapered Hip System, GT Spectron
Summary page 4
…lass: Class II Regulation 21 CFR 888.3350 and Product Code: JDI Classification panel: Orthopedic C) Predicate: K970351, K963509 Smith & Nephew Global Taper Spectron Hip Stems (for cemented hip stems) D) Device Description The Ren…
Smith & Nephew Richards, Inc.1997—
†K112897Renovis Surgical Hip Joint Replacement ProsthesisRenovis Surgical Technologies, LLC2012—
†K131354Renovis Bipolar Hip SystemRenovis Surgical Technologies, LLC2013—

Also cleared against K970351: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 2 ancestors has a recall.
  • 3 other devices also cite its predicate K970351.

How does its category compare?

All JDI devices

JDI Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Cemented: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · JDI

1in 2025

2007: 32008: 52009: 32011: 22012: 42013: 32014: 32015: 32016: 42017: 12018: 12019: 22020: 72021: 32022: 32023: 22024: 32025: 12026 (partial year): 2
2007high 7 (2020) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JDI

59in 2024

2007: 81 days median2008: 96 days median2009: 65 days median2012: 167 days median2013: 176 days median2014: 98 days median2015: 190 days median2016: 166 days median2020: 247 days median2021: 162 days median2022: 69 days median2024: 59 days median
2007high 247 (2020) · low 59 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JDI

1in 2025

2007: 262008: 62009: 32010: 32011: 52012: 42013: 112014: 32015: 12016: 52017: 52018: 12019: 12020: 772025: 1
2007high 77 (2020) · low 0 (2021)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JDI

1,644in 2025

2007: 6962008: 8102009: 9642010: 2,0402011: 3,1602012: 5,1222013: 5,2062014: 4,9682015: 4,9062016: 3,9952017: 6,1352018: 6,7282019: 7,4072020: 4,0152021: 3,1702022: 1,9782023: 1,6352024: 1,8212025: 1,644
2007high 7,407 (2019) · low 696 (2007)2025

MAUDE reports naming product code JDI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200738126696
20085966810
20093653964
20100—32,040
20112—53,160
2012416745,122
20133176115,206
201439834,968
2015319014,906
2016416653,995
20171—56,135
20181—16,728
20192—17,407
20207247774,015
2021316203,170
202236901,978
20232—01,635
202435901,821
20251—11,644
20262—0—

What is it indicated for?

The Renovis A400 Surgical Hip Replacement System is indicated for patients suffering from:

1. Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis;

2. Rheumatoid arthritis;

3. Correction of functional deformity;

4. Treatment of non-union, femoral neck fracture and trochanteric fractures of the proximal femur with head involvement, unmanageable using other techniques; and

5. Revision procedures where other treatment or devices have failed.

The Cemented Hip Stem is intended for cemented applications.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K141370: Renovis Cemented Hip System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K141370

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026